GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services
01 oct. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
INBS announces the addition of GPS Marine, a leading provider of marine construction and logistics services, to its growing number of customer accounts.
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
27 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
INBS successfully completes in-clinic testing proposed to the FDA earlier this year in its clinical study plan.
Drug Screening Market to Reach Market Valuation of USD 35.18 Billion by 2031 | SkyQuest Technology
27 sept. 2024 08h30 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Drug Screening Market will reach a value of USD 35.18 Billion by 2031, with a CAGR of 16.5% during the forecast...
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
26 sept. 2024 09h00 HE
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing for drugs of abuse, announces the release of its first-ever Education Insights Report.
UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety
25 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year
09 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
- 2024 unaudited revenue growth for the fiscal fourth quarter and full year of approximately 64% and 148% year-over-year, respectively - NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Intelligent...
Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission
05 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Drug Screening Market Trends and Opportunities Report 2024-2030: Growing Prevalence of Substance Abuse Drives Demand for Comprehensive Drug Screening Solutions
04 sept. 2024 09h55 HE
|
Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Drug Screening - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Drug Screening...
Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees
03 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a leader in non-invasive drug testing technology, today announced significant...
Psychemedics Corporation Launches New Ketamine Hair Testing Service
29 août 2024 09h00 HE
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing, announces the launch of its new ketamine hair testing solution.